NCT03311451 - C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 16, 2023

Primary Completion Date

August 1, 2025

Study Completion Date

December 1, 2026

Conditions

Barrett Esophagus

Interventions

DEVICE

C2 CryoBalloon 180° Ablation System

The C2 CryoBalloon 180° Ablation System is a cryosurgical device with a nitrous oxide cooled balloon probe that is compatible with upper gastrointestinal therapeutic endoscopes.

Trial Locations (5)

Unknown

AMC Medical Research B.V., Amsterdam

UMC Groningen, Groningen

St. Antonius Hospital, Nieuwegein

Erasmus Medical Center, Rotterdam

UMC Utrecht, Utrecht